Neurocrine Biosciences (NBIX)
51.42
-1.94 -3.64%
NASDAQ
Sep 28, 20:00
Delayed 2m
USD
View All Key Stats
NBIX Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.42 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -123.29M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 4.461B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 11.71 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -16.58M |
| Return on Equity (TTM) | -- |
View All NBIX News
NBIX News
-
WireHeadlineTime (ET)
-
Yahoo09/23 16:32
-
Yahoo09/22 10:52
-
PR Newswire09/20 07:35
-
noodls09/17 05:18
-
noodls09/17 05:18
-
PR Newswire09/07 16:05
-
PR Newswire09/01 13:00
-
MT Newswires08/31 16:14
-
Yahoo08/31 16:03
-
PR Newswire08/31 16:02
View All Events
NBIX Events
| Date | Type | Description |
|---|---|---|
| 08/03/2016 17:00 EDT | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2016 |
| 08/03/2016 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings in 2016 Release |
| 05/20/2016 | Misc | Neurocrine Biosciences Inc Annual General Meeting in 2015 |
| 05/05/2016 17:00 EDT | Misc | Neurocrine Biosciences Inc First Quarter Earnings Conference Call in 2016 |
| 05/05/2016 | Earnings | Neurocrine Biosciences Inc First Quarter Earnings in 2016 Release |
| 02/11/2016 16:30 EST | Misc | Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call in 2015 |
| 02/11/2016 | Earnings | Neurocrine Biosciences Inc Fourth Quarter Earnings in 2015 Release |
| 10/29/2015 08:00 EDT | Misc | Neurocrine Biosciences Inc Third Quarter Earnings Conference Call in 2015 |
| 10/29/2015 | Earnings | Neurocrine Biosciences Inc Third Quarter Earnings in 2015 Release |
NBIX Fundamentals
Income Statement View Statement
NBIX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.neurocrine.com
- Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
- HQ State/Province: California
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: August 03, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: December 29, 1995
- Description: Neurocrine Biosciences Inc discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.
NBIX Comparables
EditNBIX Excel Add-In Codes
- Name: =YCI("NBIX","name")
- Description: =YCI("NBIX","description")
- Sector: =YCI("NBIX","sector")
- Industry: =YCI("NBIX","industry")
- Est. Current Fiscal Year End: =YCI("NBIX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NBIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NBIX Tweets Stocktwits
Advertisement